Filed pursuant to Rule 424(b)(5)
Registration No. 333-277140
PROSPECTUS SUPPLEMENT
(To Prospectus dated
February 16, 2024)
$2,000,000,000
PPL Corporation
Common Stock
We may offer
and, if applicable, sell shares of our common stock having an aggregate offering price of up to $2,000,000,000 under an equity distribution agreement, dated February 14, 2025 (the Equity Distribution Agreement), including pursuant
to forward sale agreements entered into pursuant to the Equity Distribution Agreement.
We have entered into the Equity Distribution
Agreement with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia
Capital (USA) Inc. and Wells Fargo Securities, LLC as our agents (each, a Sales Agent, and, collectively, the Sales Agents), Barclays Bank PLC, Bank of America, N.A., Goldman Sachs & Co. LLC, JPMorgan Chase Bank,
National Association, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, Royal Bank of Canada, The Bank of Nova Scotia and Wells Fargo Bank, National Association (each, in its capacity as purchaser under any forward sale agreement (as
described below), a Forward Purchaser and collectively, the Forward Purchasers) and Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan
Stanley & Co. LLC, RBC Capital Markets, LLC, Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC (each, as agent for its affiliated Forward Purchaser in connection with the offering and sale of any shares of our common stock hereunder
in connection with a forward sale agreement (as described below), a Forward Seller and collectively, the Forward Sellers). This prospectus supplement, together with the accompanying prospectus, relates to shares of our common
stock that may be offered and sold under the Equity Distribution Agreement.
The shares of our common stock will be offered at market
prices prevailing at the time of sale. We will pay each Sales Agent a commission equal to up to 2.0% of the sales price of all shares of our common stock sold through it as our Sales Agent under the Equity Distribution Agreement.
The Equity Distribution Agreement provides that, in addition to the issuance and sale of shares of our common stock by us through or to the
Sales Agents, we may also enter into one or more forward sale agreements under the applicable master forward confirmation and the related supplemental confirmation between us and each of the Forward Purchasers. In connection with any forward sale
agreement, the relevant Forward Purchaser will borrow from third parties and, through its affiliated Forward Seller, sell a number of shares of our common stock equal to the number of shares of our common stock underlying the particular forward sale
agreement.
In connection with any forward sale agreement, the relevant Forward Seller will receive, in the form of a reduced initial
forward sale price under the related forward sale agreement, commissions at a mutually agreed rate that will not exceed, but may be lower than, 2.0% of the gross sales prices of all borrowed shares of our common stock sold during the applicable
forward hedge selling period by it as a Forward Seller. In connection with the sale of the common stock on our behalf, each Sales Agent, Forward Purchaser or Forward Seller may be deemed to be an underwriter within the meaning of the
Securities Act, and the compensation paid to each Sales Agent, Forward Purchaser or Forward Seller may be deemed to be underwriting commissions or discounts. We have also agreed to indemnify each Sales Agent, Forward Purchaser and Forward Seller
with respect to certain liabilities, including liabilities under the Securities Act of 1933, as amended (the Securities Act) or the Securities Exchange Act of 1934, as amended (the Exchange Act) or contribute to payments that
such Sales Agent, Forward Purchaser or Forward Seller may be required to make in respect of those liabilities.
Our common
stock is listed on the New York Stock Exchange under the symbol PPL. The last reported sale price of our common stock on February 13, 2025 was $34.41 per share.
Investing in our common stock involves certain risks. See Risk Factors beginning on page S-4 of this prospectus supplement, page 2 of the accompanying prospectus, and in Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2024.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon
the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
|
|
|
|
|
|
|
|
|
Barclays |
|
BofA Securities |
|
Goldman Sachs & Co. LLC |
|
J.P. Morgan |
|
Mizuho |
|
|
|
|
|
Morgan Stanley |
|
MUFG |
|
RBC Capital Markets |
|
Scotiabank |
|
Wells Fargo Securities |
The date of this prospectus supplement is February 14, 2025.